Publicacions en col·laboració amb investigadors/es de Hospital Universitario de la Princesa (22)

2024

  1. Analysis of the situation of pharmaceutical care for patients with immune-mediated inflammatory diseases before and after the COVID-19 pandemic

    Farmacia Hospitalaria

  2. Biosimilars and access to biologic therapy in immune-mediated diseases

    Expert Opinion on Biological Therapy, Vol. 24, Núm. 7, pp. 647-653

  3. Integration of persistence in the 5P-medicine approach for age-related chronic diseases

    International Journal for Quality in Health Care, Vol. 36, Núm. 2

  4. Knowledge of biological therapy for patients with immune-mediated diseases. BIOINFO Study

    Farmacia Hospitalaria

  5. The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study

    Journal of Clinical Medicine, Vol. 13, Núm. 9

  6. The value of persistence in the 5P Medicine model for chronic diseases

    Journal of Healthcare Quality Research

2023

  1. Consensus of Spanish Society of Hospital Pharmacy on optimal medication therapy management of atopic dermatitis

    Farmacia Hospitalaria, Vol. 47, Núm. 4, pp. 148-154

  2. Medicamentos inmunosupresores y biológicos en el embarazo, la lactancia y la fertilidad en enfermedades inmunomediadas

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 1, pp. 39-49

  3. The Need for the Closer Monitoring of Novel Drugs in MS: A Siponimod Retrospective Cohort Study (Realhes Study)

    Journal of Clinical Medicine, Vol. 12, Núm. 20

2022

  1. Humanization Guide of the Spanish Society of Hospital Pharmacy for patients with inflammatory immune-mediated diseases

    Farmacia Hospitalaria, Vol. 46, Núm. 6, pp. 340-351

  2. Risk of ischaemic stroke among new users of glucosamine and chondroitin sulphate: a nested case–control study

    Therapeutic Advances in Musculoskeletal Disease, Vol. 14

2021

  1. Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

    Infectious Diseases and Therapy, Vol. 10, Núm. 1, pp. 347-362

  2. Risk of acute myocardial infarction among new users of chondroitin sulfate: A nested case-control study

    PLoS ONE, Vol. 16, Núm. 7 June

2020

  1. Factors associated with long-term persistence of rituximab in rheumatoid arthritis In clinical practice: RITAR Study

    Medicina Clinica, Vol. 155, Núm. 1, pp. 1-8

  2. Risk of acute myocardial infarction among new users of bisphosphonates: a nested case–control study

    Osteoporosis International, Vol. 31, Núm. 12, pp. 2403-2412

  3. Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties

    European Journal of Medicinal Chemistry, Vol. 190

  4. Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

    The Lancet, Vol. 395, Núm. 10238, pp. 1705-1714

2017

  1. Prevalence, Incidence, and Sex Ratio of Transsexualism in the Autonomous Region of Madrid (Spain) According to Healthcare Demand

    Archives of Sexual Behavior, Vol. 46, Núm. 5, pp. 1307-1312

2015

  1. Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice

    International Journal of Clinical Pharmacy, Vol. 37, Núm. 5, pp. 808-814

2013

  1. Efficiency of adalimumab, etanercept and infliximab in rheumatoid arthritis patients: Dosing patterns and effectiveness in daily clinical practice

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 4, pp. 559-565